- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Drug cost distribution by drug type in public drug plans Canada 2017/2018
Drug cost distribution by drug type in public drug plans Canada 2017/2018
Distribution of drug costs by drug type in select public Canadian drug plans in 2017/2018
by Matej Mikulic,
last edited
Sep 11, 2019
Patented drugs had a share of nearly 63 percent of drug costs in select public Canadian drug plans. This statistic depicts the distribution of drug costs by drug type in select Canadian public drug plans in Canada as of fiscal year 2017/2018.
Distribution of drug costs by drug type in select public Canadian drug plans in 2017/2018
Loading statistic...
| Drug type | Share of drug cost |
|---|---|
| Patented* | 62.6% |
| Multi-source generic | 21% |
| Single-source non-patented | 3.8% |
| Other** | 12.6% |
| Drug type | Share of drug cost |
|---|---|
| Patented* | 62.6% |
| Multi-source generic | 21% |
| Single-source non-patented | 3.8% |
| Other** | 12.6% |
Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Register now
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Sep 11, 2019
Patented drugs had a share of nearly 63 percent of drug costs in select public Canadian drug plans. This statistic depicts the distribution of drug costs by drug type in select Canadian public drug plans in Canada as of fiscal year 2017/2018.
- Show sources information
- Show publisher information
- Release date
- 2019
- Region
- Canada
- Survey time period
- fiscal year 2017/2018
- Supplementary notes
-
This analysis only includes data for beneficiaries that met their deductible and received public reimbursement.
Direct-acting antiviral (DAA) drugs are used in the treatment of hepatitis C.
High-cost drugs have an average annual treatment cost of greater than $10,000 and include both biologics and non-biologics.
Included are: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, and the Non-Insured Health Benefits Program.
* The patented medicines market segment includes all medicines that had patent protect at some time during in the period of study, even if the patent expired during that period. As such, the 2017/18 growth does not reflect the loss of patent exclusivity for some top-selling medicines over the course of the fiscal year.
** This market segment includes devices, compounded drugs, and other products that are reimbursed by public drug plans but do not have a Health Canada assigned Drug Identification Number (DIN).
Source
- Show sources information
- Show publisher information
- Release date
- 2019
More information
- Region
- Canada
- Survey time period
- fiscal year 2017/2018
- Supplementary notes
-
This analysis only includes data for beneficiaries that met their deductible and received public reimbursement.
Direct-acting antiviral (DAA) drugs are used in the treatment of hepatitis C.
High-cost drugs have an average annual treatment cost of greater than $10,000 and include both biologics and non-biologics.
Included are: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, and the Non-Insured Health Benefits Program.
* The patented medicines market segment includes all medicines that had patent protect at some time during in the period of study, even if the patent expired during that period. As such, the 2017/18 growth does not reflect the loss of patent exclusivity for some top-selling medicines over the course of the fiscal year.
** This market segment includes devices, compounded drugs, and other products that are reimbursed by public drug plans but do not have a Health Canada assigned Drug Identification Number (DIN).
Other statistics on the topic
+Pharmaceutical Products & Market
VAT rate on prescription-only drugs in Europe 2018
+Pharmaceutical Products & Market
Research and development in European pharmaceutical industry by country 2017
Pharmaceutical Products & Market
Market share of generics in European countries 2017
Pharmaceutical Products & Market
Employment in European pharmaceutical industry by country 2017
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*European Union: share of GDP expenditure on research and development 2000-2017
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)Research and development in European pharmaceutical industry by country 2017
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2018 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2018
- Leading European pharmaceutical companies by spending on research and development in 2018 (in billion U.S. dollars)Leading European pharmaceutical companies by R&D spending 2018
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2018
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2018
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2018, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2018, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2017Employment in European pharmaceutical industry by country 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018Employment in EFPIA pharmaceutical industry 1990-2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2018 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2018
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2018Number of employees in the pharmaceutical industry in Belgium 2014-2018
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018Number of employees in the pharmaceutical industry in Italy 2000-2018
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2018Number of clinical trials authorized in Italy 2003-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: You might find this interesting as well
Statistics
- Drug dispensing cost share by drug type in public drug plans Canada 2014/15-2015/16
- Share of prescriptions by drug type in public drug plans Canada 2011-2018
- Share of drug costs by type in public drug plans Canada 2011/12 to 2017/18
- Average Rx drug cost per senior beneficiary in Canada by public drug plan 2015/2016
- Rates of change in dispensing costs in Canada by public drug plan 2015-2018
- Share of drug dispensing costs in select public drug plans Canada 2015-2018
- Number of public drug plan beneficiaries in Canada by province 2017/2018
- Public drug plan beneficiaries in Canada as share of total population 2017-2018
- Active beneficiary population change in Canadian public drug plans 2017/2018
- Rx drug expenditure in Canada by plan and type 2017/2018
- Plan-paid share of Rx drug expenditures in Canada by public plan 2017/2018
- Dispensing costs for tablets of generic drugs by public drug plan 2017/18
- Generic drugs average unit cost index in Canada by public drug plan 2013/2014
- Senior and non-senior beneficiaries share in Canada by public drug plan 2017/2018
- Change of drug cost in Canada by public drug plan 2017/2018
- Number of public drug plan prescriptions in Canada 2017/2018
- Growth in prescriptions of select drugs in Canada's public drug plans 2013/2014
- Biologics share of total drug costs in Canada by public drug plan 2017/2018
- Level 1 ATC therapy classes by share of total public drug costs in Canada 2017/2018
- Dispensing fee per prescription in Canada by drug plan 2017/2018
Statistics on "Pharmaceutical trends in Europe - Overview"
- Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Pharmaceutical price structure breakdown in Europe 2016
- VAT rate on over-the-counter drugs in Europe 2018, by country
- VAT rate on prescription-only drugs in Europe 2018
- European Union: share of GDP expenditure on research and development 2000-2017
- Research and development in European pharmaceutical industry by country 2017
- Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
- Market share of generics in European countries 2017
Statistics on "Pharmaceutical trends in Europe - European Pharmaceutical companies"
Statistics on "Pharmaceutical trends in Europe - Self-medication market"
- Self-medication market sales in Europe in 2017, by country
- Self-medication market sales of analgesics in Europe in 2017, by country
- Cough and cold self-medication market sales in Europe in 2017
- Digestives and intestinal remedies self-medication market sales in Europe 2017
- Self-medication skin treatment product sales in Europe 2017, by country
- Self-medication: sales of vitamins and minerals in Europe 2017
- Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands 2018, by purchase channel
- Revenue of self-care medicines in supermarkets in the Netherlands 2018, by segment
Statistics on "Pharmaceutical trends in Europe - Employment"
- Employment in European pharmaceutical industry by country 2017
- Employment in EFPIA pharmaceutical industry 1990-2018
- Pharmaceutical manufacturing employment in the United Kingdom 2008-2018
- Switzerland: number of employees in biotech companies 2012-2017
- Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium 2014-2018
- Number of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy 2000-2018
Statistics on "Pharmaceutical trends in Europe - Clinical Trials"
- Distribution of European clinical and phase III pipeline 2013 by indication
- Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Patients in clinical trials in selected European countries 2005-2011
- Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized in Italy 2003-2018
Further related statistics
- Drug dispensing cost share by drug type in public drug plans Canada 2014/15-2015/16
- Share of prescriptions by drug type in public drug plans Canada 2011-2018
- Share of drug costs by type in public drug plans Canada 2011/12 to 2017/18
- Average Rx drug cost per senior beneficiary in Canada by public drug plan 2015/2016
- Rates of change in dispensing costs in Canada by public drug plan 2015-2018
- Share of drug dispensing costs in select public drug plans Canada 2015-2018
- Number of public drug plan beneficiaries in Canada by province 2017/2018
- Public drug plan beneficiaries in Canada as share of total population 2017-2018
- Active beneficiary population change in Canadian public drug plans 2017/2018
- Rx drug expenditure in Canada by plan and type 2017/2018
- Plan-paid share of Rx drug expenditures in Canada by public plan 2017/2018
- Dispensing costs for tablets of generic drugs by public drug plan 2017/18
- Generic drugs average unit cost index in Canada by public drug plan 2013/2014
- Senior and non-senior beneficiaries share in Canada by public drug plan 2017/2018
- Change of drug cost in Canada by public drug plan 2017/2018
- Number of public drug plan prescriptions in Canada 2017/2018
- Growth in prescriptions of select drugs in Canada's public drug plans 2013/2014
- Biologics share of total drug costs in Canada by public drug plan 2017/2018
- Level 1 ATC therapy classes by share of total public drug costs in Canada 2017/2018
- Dispensing fee per prescription in Canada by drug plan 2017/2018
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$59 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.